| |
| Magyar Kardiológusok Társasága |
|
| 3. Pécsi Kardiovaszkuláris Prevenciós és Rehabilitációs Kongresszus |
 Rendezvény kezdete: 2017.09.28. | Rendezvény vége: 2017.09.30. |
| Helyszín: 7622 Pécs, Breuer Marcell sétány 4., Kodály Központ |
Fő témák:
- A CV betegségek primer prevenciója: helyzetértékelés, jövőbeni tervek, lehetőségek
- Újdonságok a kardiológiában: RF management a 2016-os prevenciós guideline alapján. Antikoaguláns és antithrombocyta kezelés az új irányelvek alapján
- Az obesitas szerepe a CV betegségek kialakulásában. Megoldási lehetőségek a megelőzésben és a kezelésben
- Fizikai aktivitás: erőnlét, terhelhetőség megítélése. Fizikai tréning program CV esemény illetve beavatkozás után
- Telemedicina a kardiológiában
- Kardiológiai rehabilitáció speciális helyzetekben: időskor, veseelégtelenség, COPD, szívelégtelenség
- Újdonságok a sport kardiológia területén
- Pszichoszociális rizikófaktorok és kezelésük
Tudományos program:
Dr. Szabados Eszter
PTE kk I.sz. Belgyógyászati Klinika 7623 Pécs, Rákóczi út 2.
tel: 72-533-133; e-mail: szabados.eszter@pte.hu
Rendezvényszervezés:
Convention Budapest Kft.
Miklósi Ferenc
tel: 06-1-323-27-54, e-mail: fmiklosi@convention.hu
További információ, jelentkezés, absztrakt beküldés:
http://www.convention.hu/Rendezveny/Reszletek/PKPRK2017 |
|
|
 |
| |
| Magyar Immunológiai Társaság |
|
| C-HEP 2012 - 2nd World Congress on Controversies in the Management of Viral Hepatitis (C-Hep) |
| Rendezvény kezdete: 2012.10.18. | Rendezvény vége: 2012.10.20. |
| Helyszín: Germany / Németország, Berlin, |
| A rendezvény Web oldala: http://comtecmed.com/chep/2012/Default.aspx |
Dear Friends and Colleagues,
Following the success of the 1st World Congress on Controversies in the Management of Viral Hepatitis (C-Hep), we are very pleased to invite you to participate in the 2nd C-Hep Congress which will be held in Berlin, Germany on October 18-20, 2012.
The large attendance and enthusiastic feedback of the 1st Congress held last May in Barcelona highlighted the need for such a meeting focusing on the needs of the busy clinician caring for HCV and HBV infected patients. The C-Hep Congress attempts to summarize all the key new data recently presented – and how it might be implemented in routine care of Hepatitis B and C patients. Overviews, state of the art lectures and controversial debates with the outstanding faculty of prominent world leaders presenting both pro and con positions challenge and explore the optimal treatment for patients, including the appropriate use of new drugs. This educational Congress focuses on clinical practices in Viral Hepatitis and benefits not only Hepatologists and Infectious Diseases specialist, but also general practitioners, internists and primary care physicians with a desire to gain knowledge in these exciting advances.
The format includes a significant allocation of time for interactive debates and questions from the audience to each panel of experts. Participants are encouraged to take an active role in the discussions with faculty members which follow each debate, in a unique and open environment.
We look forward to welcoming you at the 2nd C-Hep Congress in the lovely city of Berlin.
Sincerely,
Jürgen Rockstroh MD (Germany) and Jonathan M. Schapiro MD (Israel)
(Co-Chairpersons) |
|
|
|
| |
| Magyar Immunológiai Társaság |
|
| C-HEP 2012 - 2nd World Congress on Controversies in the Management of Viral Hepatitis (C-Hep) |
| Rendezvény kezdete: 2012.10.18. | Rendezvény vége: 2012.10.20. |
| Helyszín: Germany / Németország, Berlin, |
| A rendezvény Web oldala: http://comtecmed.com/chep/2012/Default.aspx |
Dear Friends and Colleagues,
Following the success of the 1st World Congress on Controversies in the Management of Viral Hepatitis (C-Hep), we are very pleased to invite you to participate in the 2nd C-Hep Congress which will be held in Berlin, Germany on October 18-20, 2012.
The large attendance and enthusiastic feedback of the 1st Congress held last May in Barcelona highlighted the need for such a meeting focusing on the needs of the busy clinician caring for HCV and HBV infected patients. The C-Hep Congress attempts to summarize all the key new data recently presented – and how it might be implemented in routine care of Hepatitis B and C patients. Overviews, state of the art lectures and controversial debates with the outstanding faculty of prominent world leaders presenting both pro and con positions challenge and explore the optimal treatment for patients, including the appropriate use of new drugs. This educational Congress focuses on clinical practices in Viral Hepatitis and benefits not only Hepatologists and Infectious Diseases specialist, but also general practitioners, internists and primary care physicians with a desire to gain knowledge in these exciting advances.
The format includes a significant allocation of time for interactive debates and questions from the audience to each panel of experts. Participants are encouraged to take an active role in the discussions with faculty members which follow each debate, in a unique and open environment.
We look forward to welcoming you at the 2nd C-Hep Congress in the lovely city of Berlin.
Sincerely,
Jürgen Rockstroh MD (Germany) and Jonathan M. Schapiro MD (Israel)
(Co-Chairpersons) |
|
|
|
| |
| Magyar Immunológiai Társaság |
|
| C-HEP 2012 - 2nd World Congress on Controversies in the Management of Viral Hepatitis (C-Hep) |
| Rendezvény kezdete: 2012.10.18. | Rendezvény vége: 2012.10.20. |
| Helyszín: Germany / Németország, Berlin, |
| A rendezvény Web oldala: http://comtecmed.com/chep/2012/Default.aspx |
Dear Friends and Colleagues,
Following the success of the 1st World Congress on Controversies in the Management of Viral Hepatitis (C-Hep), we are very pleased to invite you to participate in the 2nd C-Hep Congress which will be held in Berlin, Germany on October 18-20, 2012.
The large attendance and enthusiastic feedback of the 1st Congress held last May in Barcelona highlighted the need for such a meeting focusing on the needs of the busy clinician caring for HCV and HBV infected patients. The C-Hep Congress attempts to summarize all the key new data recently presented – and how it might be implemented in routine care of Hepatitis B and C patients. Overviews, state of the art lectures and controversial debates with the outstanding faculty of prominent world leaders presenting both pro and con positions challenge and explore the optimal treatment for patients, including the appropriate use of new drugs. This educational Congress focuses on clinical practices in Viral Hepatitis and benefits not only Hepatologists and Infectious Diseases specialist, but also general practitioners, internists and primary care physicians with a desire to gain knowledge in these exciting advances.
The format includes a significant allocation of time for interactive debates and questions from the audience to each panel of experts. Participants are encouraged to take an active role in the discussions with faculty members which follow each debate, in a unique and open environment.
We look forward to welcoming you at the 2nd C-Hep Congress in the lovely city of Berlin.
Sincerely,
Jürgen Rockstroh MD (Germany) and Jonathan M. Schapiro MD (Israel)
(Co-Chairpersons) |
|
|
|
